4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-020876
Chief Financial Officer sold 9,200 shares at $18.52 ($170,348)
- Chief Financial Officer acquired 9,200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hyep Ivan Chief Financial Officer | 2026-03-23 | Option exercise 10b5-1 | +9,200 | $3.79 | $34,866 | 154,555 | D |
| Hyep Ivan Chief Financial Officer | 2026-03-23 | Sale 10b5-1 | −9,200 | $18.52 | $170,348 | 145,355 | D |
| Derivatives | |||||||
| Hyep Ivan Chief Financial Officer | 2026-03-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,200 | 48,944 | D | ||
| Open-market sales · 9,200 sh · avg $18.52 · $170,348 | |||||||
Loading xslF345X06/wk-form4_1774395899.xml…